[{"Assets_0_Q3_USD":456254000.0,"CommonStockSharesOutstanding_0_Q3_shares":15429154.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-29342000.0,"NetIncomeLoss_1_Q3_USD":-21429000.0,"NetIncomeLoss_3_Q3_USD":-56208000.0,"StockholdersEquity_0_Q3_USD":440349000.0,"Ticker":"MDGL","CIK":"1157601","name":"MADRIGAL PHARMACEUTICALS, INC.","OfficialName":"Madrigal Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1322434501.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191106"}]